Internal Medicine Alert - October 30, 2011

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Internal Medicine Alert has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins 01/01/11. Term of approval is for one year from this date. Credit may be claimed for 1 year from the date of each issue.

Faculty

Executive Editor
Stephen A. Brunton, MD

Clinical Professor
University of California, Irvine

Associate Editors
Rahul Gupta, MD, MPH, FACP
Clinical Assistant Professor,
West Virginia University School of Medicine
Charleston, WV

William T. Elliott, MD, FACP
Chair, Formulary Committee
Northern California Kaiser Permanente
Asst. Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Authors
Alan Z. Segal, MD
Associate Professor of Clinical Neurology
Weill Cornell Medical College
New York, NY

Frank W. Ling, MD
Clinical Professor
Department of Obstetrics and Gynecology
Vanderbilt University School of Medicine
Nashville, TN

Andrew J. Boyle, MBBS, PhD
Assistant Professor of Medicine
Interventional Cardiology
University of California
San Francisco, CA

Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Subjects:

  • Replacing Warfarin for Atrial Fibrillation Treatment — A Foregone Conclusion!
  • Strokes More Severe When Occurring During Sleep
  • A Better Understanding of Nocturia in Patients with Interstitial Cystitis
  • ACE Inhibitors/ARBs for Aortic Stenosis?
  • Vemurafenib Tablets (Zelboraf™)
  • Clinical Briefs

Objectives:

  • describe new findings in differential diagnosis and treatment of various diseases
  • describe controversies, advantages, and disadvantages of those advances
  • describe cost-effective treatment regimens
  • describe the pros and cons of new screening procedures.

Financial Disclosure:

Internal Medicine Alert's editor, Stephen Brunton, MD, serves on the advisory board for Amylin, Boehringer Ingelheim, Novo Nordisk, and Symbiotix; he serves on the speakers bureau of Boehringer Ingelheim, Novo Nordisk, and Teva. Associate editors Rahul Gupta, MD, MPH, FACP, William T. Elliott, MD, FACP, and James Chan, PharmD, PhD, authors Alan Z. Segal, MD, Frank W. Ling, MD, Andrew J. Boyle, MBBS, PhD, and peer reviewer Gerald Roberts, MD; executive editor Leslie Coplin; and managing editor Neill Kimball report no financial relationships relevant to this field of study. Associate editor Louis Kuritzky, MD is an advisor for Endo, Kowa, Pricara, and Takeda.

Copyright 2011 AHC Media LLC. All rights reserved.